Propolis Extract with Activity Against Cutibacterium acnes Biofilm Targeting the Expression of Virulence Genes
Antioxidants · 10.07.2025 · 14 (7) · 849
DOI: 10.3390/antiox14070849 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 10.07.2025. Verfasst von Sophia Athanasopoulou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development Department, APIVITA SA, Industrial Park Markopoulo Mesogaias, 19003 Athens, Greece. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Acne is a highly prevalent skin condition with multifactorial pathophysiology, where Cutibacterium acnes (C. acnes) overgrowths generate inflammation. C. acnes can grow and adhere, through the formation of biofilms, to almost any surface, which enables chronic infections. Acne treatment with antibiotics can induce topical antimicrobial resistance, impair microbiome biodiversity and cause cutaneous dysbiosis. In this study, we assess the effect of a standardized propolis extract (PE) from Greece against C. acnes, whilst maintaining skin’s microbiome biodiversity, and we investigate its effect against genes related to the attachment and colonization of C. acnes, as well as against biofilm formation. The extract has been chemically characterized by GC-MS and was additionally tested for its antioxidant properties by the Folin–Ciocalteu method and the 2,2-Diphenyl-1-Picrylhydrazyl (DPPH) assay and its regulatory activity on the expression of antimicrobial and anti-inflammatory genes in normal human epidermal keratinocytes (NHEKs). The suggested efficacy of PE in targeting pathogenic C. acnes biofilm, via downregulation of virulence genes, represents an alternative strategy to modulate the behavior of skin microbiota in acne, paving the way for next-generation acne-targeting products.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research and Development Department, APIVITA SA, Industrial Park Markopoulo Mesogaias, 19003 Athens, Greece.
- Biomedical Research Foundation, Academy of Athens, 11527 Athens, Greece.
- Laboratory of Pharmacognosy and Chemistry of Natural Products, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Zografou, 15771 Athens, Greece.
- Molecular Microbiology Department, QACS The Challenge Test Laboratory, Antigonis 1, 14451 Metamorfosi, Greece.
- Department of Pharmacy, Frederick University, Nicosia 1036, Cyprus.
ORCID-Profile: Eleni Panagiotidou, Athanasios K Anagnostopoulos, Konstantinos Gardikis
Zitieren
APA
Athanasopoulou, S., Panagiotidou, E., Spanidi, E., Gkika, M., Georgiou, D., Anagnostopoulos, A. K., Ganos, C., Chinou, I., Beletsiotis, E., & Gardikis, K. (2025). Propolis Extract with Activity Against Cutibacterium acnes Biofilm Targeting the Expression of Virulence Genes. Antioxidants, 14(7), 849. https://doi.org/10.3390/antiox14070849
Vancouver
Athanasopoulou S, Panagiotidou E, Spanidi E, Gkika M, Georgiou D, Anagnostopoulos AK, et al. Propolis Extract with Activity Against Cutibacterium acnes Biofilm Targeting the Expression of Virulence Genes. Antioxidants. 2025;14(7):849. doi:10.3390/antiox14070849
BibTeX
@article{Athanasopoulou2025,
author = {Athanasopoulou, Sophia and Panagiotidou, Eleni and Spanidi, Eleni and Gkika, Maria and Georgiou, Danai and Anagnostopoulos, Athanasios K and Ganos, Christos and Chinou, Ioanna and Beletsiotis, Evangelos and Gardikis, Konstantinos},
title = {Propolis Extract with Activity Against Cutibacterium acnes Biofilm Targeting the Expression of Virulence Genes},
journal = {Antioxidants},
year = {2025},
volume = {14},
number = {7},
pages = {849},
doi = {10.3390/antiox14070849}
}
EUVIMED